Filter Results:
(90)
Show Results For
- All HBS Web
(730)
- Faculty Publications (90)
Show Results For
- All HBS Web
(730)
- Faculty Publications (90)
←
Page 5 of 90
Results
- August 2001
- Case
Scios, Inc.
Scios, filled with distinguished scientists and experienced managers, nevertheless fails to clear the FDA Phase III process for an important biotechnology drug. This case asks the students to analyze the social costs and benefits of the regulatory process. View Details
- December 1999
- Case
Sun Microsystems, Inc. (A2): Network Visions: Mike Clary on the Product that Hid in HR
By: Rosabeth M. Kanter and Jane Roessner
Chief scientist Bill Joy of Sun Microsystems, Inc. had a vision for a new product called "Jini": a network computing piece of infrastructure that would reinforce Sun's leadership role in the industry for helping define how the Internet and networking technology... View Details
- January 1996
- Case
Biogen, Inc.: rBeta Interferon Manufacturing Process Development
Biogen, Inc., a Cambridge, MA-based biotechnology company, is wrapping up a project to develop a new manufacturing process for a new drug product that will reposition the company from a purely research-oriented company to a fully integrated pharmaceutical manufacturing... View Details
Keywords: Learning; Technological Innovation; Management Analysis, Tools, and Techniques; Product Development; Organizational Change and Adaptation; Projects; Research and Development; Corporate Strategy; Biotechnology Industry
Wheelwright, Steven C. "Biogen, Inc.: rBeta Interferon Manufacturing Process Development." Harvard Business School Case 696-083, January 1996.
- January 1990 (Revised October 1993)
- Case
Monsanto's March into Biotechnology (A)
By: Gary P. Pisano
Very early in the history of biotechnology (about 1979), Monsanto made a major commitment to move into this field. This case recounts the history from the point of view of the eminent scientist hired to head up corporate R&D. He took Monsanto from a very traditional... View Details
Pisano, Gary P. "Monsanto's March into Biotechnology (A)." Harvard Business School Case 690-009, January 1990. (Revised October 1993.)
- September 1988 (Revised July 2000)
- Case
Alex Dean
By: Shoshana Zuboff, Dave DeLong and Kathleen Scharf
Traces the evolution of Alex Dean's internal and external careers, exploring his psychological and emotional development, as well as seemingly dramatic shifts in career direction from research scientist to venture capitalist. Designed to encourage students to reflect... View Details
Keywords: Personal Development and Career; Jobs and Positions; Emotions; Research and Development; Venture Capital
Zuboff, Shoshana, Dave DeLong, and Kathleen Scharf. "Alex Dean." Harvard Business School Case 489-039, September 1988. (Revised July 2000.)
- Research Summary
Current Research
By: Leslie K. John
Professor John is a behavioral scientist who uses both laboratory and field experiments to investigate questions that are at the intersection of marketing, organizational behavior, and public policy.
Professor John’s work has been published in leading... View Details
- Research Summary
Overview
By: Kyle R. Myers
Professor Myers studies the economics of what determines the rate and direction of innovation. He has examined the reallocation of scientists through the use of targeted research grants at the National Institutes of Health, and is working to further understand how... View Details
Keywords: Technology Networks; Commercialization; Science-Based Business; Research and Development; Knowledge Management; Patents; Innovation Strategy; Technological Innovation; Health Care and Treatment; Entrepreneurship; Health; Innovation and Invention; Science; Technology; Knowledge; Intellectual Property; Economics; Microeconomics; Biotechnology Industry; Health Industry; Pharmaceutical Industry; Technology Industry
- Research Summary
Reforming Social Science
By: Max H. Bazerman
Social science research affects all of us. When researchers learned organ donation rates are higher in countries where human organs are automatically available for donation unless you specifically “opt-out” of the system, as opposed to countries like the U.S., where... View Details
- Research Summary
Risk, Trust and Escalation Behavior of Owner Managers
Professor Montgomery and Professor Deepak Malhotra (HBS), together with scientists from Harvard's Program on Evolutionary Dynamics, are studying risk-related decision making of owner managers in newly-founded and established companies. This experimental... View Details
- Research Summary
The Business of Stem Cells
By: Debora L. Spar
In 2004, the topic of stem cell research made both medical and moral headlines. Buoyed by a series of technological breakthroughs, stem cell scientists grew increasingly convinced that they would eventually be able to use embryonic stem cells -- the pluripotent cells... View Details